Vir Biotechnology Inc expected to post a loss of $1.20 a share - Earnings Preview

Vir Biotechnology

02/08/2023 03:04

* Vir Biotechnology Inc  VIR.OQ   VIR.O  is expected
to report
results on August 3.
    * The San Francisco California-based  company is expected to
report revenue of $25.886 million, according to the mean
estimate from 6 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Vir Biotechnology
Inc is
for a loss of $1.20 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Vir
Biotechnology
Inc is $26​, above​ its last closing price of $14.24. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.74       -0.87      -1.06     Missed  -21.2
 Dec. 31 2023  -0.25       -0.39      -0.76     Missed  -92.4
 Sep. 30 2022  -0.21       -0.21      1.30      Beat    710.3​
 Jun. 30 2022  0.16        0.10       -0.58     Missed  -653.7
 ​​Mar.        3.83        3.78       3.85      Beat    1.9
 31 2022                                                
 Dec. 31 2021  4.42        3.04       3.92      Beat    28.9​
 Sep. 30 2021  0.04        0.02       0.82      Beat    3,487.
                                                        1
 Jun. 30 2021  -0.57       -0.48      0.46      Beat    196.4
 This summary was machine generated August 2 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated